Upfront Therapies and Downstream Effects: Navigating Late Effects in Childhood Cancer Survivors in the Current Era

Rachel Phelan(Children's Hospital of Wisconsin), K. Scott Baker(University of Washington), Hesham Eissa(St. Jude Children's Research Hospital), Lauren Pommert(Cincinnati Children's Hospital Medical Center), Brandon Nuechterlein(University of Colorado Cancer Center), Kerri Becktell(Medical College of Wisconsin), Ryuma Tanaka(Medical College of Wisconsin), Matthew R. Kudek(Medical College of Wisconsin), Neel S. Bhatt(The Ohio State University Wexner Medical Center)
Current Oncology Reports
November 25, 2019
10.1007/s11912-019-0861-8
Cited by 6

Related Papers

The cumulative burden of surviving childhood cancer: an initial report from the St Jude Lifetime Cohort Study (SJLIFE)
|The Lancet|2017|856
Current Use of and Trends in Hematopoietic Cell Transplantation in the United States
|Transplantation and Cellular Therapy|2020|718
Late mortality after allogeneic hematopoietic cell transplantation and functional status of long-term survivors: report from the Bone Marrow Transplant Survivor Study
|Blood|2007|536
Effect of baclofen on cocaine self-administration in rats reinforced under fixed-ratio 1 and progressive-ratio schedules
|Psychopharmacology|2000|148
Excellent outcomes following hematopoietic cell transplantation for Wiskott-Aldrich syndrome: a PIDTC report
|Blood|2020|142